FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR

Clinical trial NCT00810030 · COMPLETED

Trial details

NCT number: NCT00810030
Sponsor: Vifor Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammatory Bowel Disease Anemia Iron Deficiency Iron-Deficiency Anemia Crohn's Disease Ulcerative Colitis

Start date: 2008-10-01
Primary completion: 2009-12-01
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.